NVST · ISSUER CIK 1757073
Envista Holdings Corp
Between Aug 1, 2026 and Oct 29, 2026, 6 Envista Holdings Corp insiders reported $0.00 of open-market purchases and $220K of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$220KInsider selling
−$220KNet open-market
Aug 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 202616:25 | Aug 25, 2026 | NVST | President, Orthodontics | F · Tax | $27.47 | −7,710 | 48,806 | -14% | $212K | ||
| Aug 27, 202616:23 | Aug 25, 2026 | NVST | President, Diagnostics | F · Tax | $27.47 | −5,147 | 45,785 | -10% | $141K | ||
| Aug 27, 202616:21 | Aug 25, 2026 | NVST | Chief Financial Officer | F · Tax | $27.47 | −10,885 | 99,913 | -10% | $299K | ||
| Aug 27, 202616:19 | Aug 25, 2026 | NVST | President, Nobel Biocare | F · Tax | $27.47 | −804 | 61,560 | -1% | $22K | ||
| Aug 24, 202616:25 | Aug 20, 2026 | NVST | SVP, Strategy & Bus. Dev. | S · Sell10b5-1 | $27.50 | −8,000 | 27,321 | -23% | −$220K | ||
| Aug 20, 202616:15 | Aug 18, 2026 | NVST | Chief Executive Officer, Director | A · Grant | — | +179,730 | 551,304 | +48% | — |